Individual and synergistic anti-coronavirus activities of socs1/3 antagonist and interferon α1 peptides

HIGHLIGHTS

• who: Chulbul M. Ahmed and colleagues from the Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL, United States, Department of have published the research: Individual and Synergistic Anti-Coronavirus Activities of SOCS1/3 Antagonist and Interferon u03b11 Peptides, in the Journal: (JOURNAL)
• what: The authors demonstrate that the SOCS1/3 antagonist peptide (pJAK2) inhibits cell toxicity and viral release of HuCoV-OC43 in cell culture. To determine if this approach might be effective against the agent of COVID-19, the authors show that pJAK2 peptide blocks the replication and release of SARS . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.